Gainers
- HTG Molecular Diagnostics Inc (NASDAQ:HTGM) rose 69 percent to $6.64 in pre-market trading after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
- ZAIS Group Holdings, Inc. (NASDAQ:ZAIS) shares rose 43 percent to $3.23 in pre-market trading. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
- Eleven Biotherapeutics Inc (NASDAQ:EBIO) rose 21.6 percent to $2.31 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
- Micron Technology, Inc. (NASDAQ:MU) rose 13.3 percent to $30.00 in pre-market trading after the company reported better-than-expected earnings for its second quarter and issued a strong forecast for the third quarter.
- Sophiris Bio Inc (NASDAQ:SPHS) rose 9 percent to $2.810 in pre-market trading. Sophiris reported that data from its Phase 2a study of topsalysin will be presented at the 32nd Annual European Association of Urology in London, UK.
- ImmunoCellular Therapeutics Ltd (NYSE:IMUC) rose 7.1 percent to $2.87 in pre-market trading after gaining 8.94 percent on Thursday.
- China Distance Education Hldgs Ltd (ADR) (NYSE:DL) shares rose 5.5 percent to $10.60 in pre-market trading after slipping 0.99 percent on Thursday.
- Western Digital Corp (NASDAQ:WDC) shares rose 4 percent to $79.17 in pre-market trading after gaining 1.68 percent on Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- Xenon Pharmaceuticals Inc (NASDAQ:XENE) fell 44.2 percent to $5.50 in pre-market trading after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.
- Medigus Ltd. (NASDAQ:MDGS) fell 23.4 percent to $3.38 in pre-market trading. Medigus announced a $7.5 million offering for Class A and B shares.
- Finish Line Inc (NASDAQ:FINL) shares fell 15.9 percent to $13.51 in pre-market trading after the company reported weaker-than-expected earnings for its fourth quarter.
- Sportsman's Warehouse Holdings Inc (NASDAQ:SPWH) fell 11.7 percent to $4.44 in pre-market trading after the company reported downbeat results for its fourth quarter and issued a weak outlook for the current quarter.
- GameStop Corp. (NYSE:GME) shares fell 11 percent to $21.32 in pre-market trading. GameStop reported upbeat earnings for its fourth quarter, but sales missed estimates. The company also issued a weak earnings forecast for FY 2017.
- CymaBay Therapeutics Inc (NASDAQ:CBAY) fell 8.7 percent to $3.48 in pre-market trading. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
- Condor Hospitality Trust, Inc. (NASDAQ:CDOR) shares fell 6.8 percent to $10.50 in the pre-market trading session. Condor Hospitality Trust priced its public offering of 4.15 million shares of common stock at $10.50 per share.
- Vipshop Holdings Ltd - ADR (NYSE:VIPS) fell around 5.8 percent to $13.00 in pre-market trading after gaining 0.15 percent on Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.